First Time Loading...

Agilent Technologies Inc
NYSE:A

Watchlist Manager
Agilent Technologies Inc Logo
Agilent Technologies Inc
NYSE:A
Watchlist
Price: 132.73 USD 0.22% Market Closed
Updated: Apr 20, 2024

ROE
Return on Equity

21%
Current
23%
Average
-2.7%
Industry
Positive for the last year
21%
Positive average
23%
Worse than average
Better than industry value

ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.

ROE
21%
=
Net Income
1.2B
/
Equity
5.9B

ROE Across Competitors

ROE Comparison
Agilent Technologies Inc Competitors

Country Company Market Cap ROE
US
Agilent Technologies Inc
NYSE:A
39B USD
21%
US
Thermo Fisher Scientific Inc
NYSE:TMO
210.2B USD
13%
US
Danaher Corp
NYSE:DHR
173.7B USD
9%
US
IQVIA Holdings Inc
NYSE:IQV
41.3B USD
23%
KR
Samsung Biologics Co Ltd
KRX:207940
55.6T KRW
9%
CH
Lonza Group AG
SIX:LONN
36.2B CHF
7%
US
West Pharmaceutical Services Inc
NYSE:WST
27.7B USD
21%
US
Mettler-Toledo International Inc
NYSE:MTD
25.6B USD
-1 261%
IE
ICON PLC
NASDAQ:ICLR
23.8B USD
7%
FR
Sartorius Stedim Biotech SA
PAR:DIM
18.5B EUR
12%
US
Illumina Inc
NASDAQ:ILMN
18.7B USD
-19%
Agilent Technologies Inc
NYSE:A
Country US
Market Cap 39B USD
ROE
21%
Thermo Fisher Scientific Inc
NYSE:TMO
Country US
Market Cap 210.2B USD
ROE
13%
Danaher Corp
NYSE:DHR
Country US
Market Cap 173.7B USD
ROE
9%
IQVIA Holdings Inc
NYSE:IQV
Country US
Market Cap 41.3B USD
ROE
23%
Samsung Biologics Co Ltd
KRX:207940
Country KR
Market Cap 55.6T KRW
ROE
9%
Lonza Group AG
SIX:LONN
Country CH
Market Cap 36.2B CHF
ROE
7%
West Pharmaceutical Services Inc
NYSE:WST
Country US
Market Cap 27.7B USD
ROE
21%
Mettler-Toledo International Inc
NYSE:MTD
Country US
Market Cap 25.6B USD
ROE
-1 261%
ICON PLC
NASDAQ:ICLR
Country IE
Market Cap 23.8B USD
ROE
7%
Sartorius Stedim Biotech SA
PAR:DIM
Country FR
Market Cap 18.5B EUR
ROE
12%
Illumina Inc
NASDAQ:ILMN
Country US
Market Cap 18.7B USD
ROE
-19%

Profitability Report

View the profitability report to see the full profitability analysis for Agilent Technologies Inc.

Full Profitability Report

See Also

Summary
A intrinsic value, competitors valuation, and company profile.
DCF Valuation
A stock valuation using Discount Cash Flow valuation method.
Relative Valuation
A stock valuation using valuation multiples.
Wall Street Estimates
A price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
A stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Return on Equity?

ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.

ROE
21%
=
Net Income
1.2B
/
Equity
5.9B
What is the ROE of Agilent Technologies Inc?

Based on Agilent Technologies Inc's most recent financial statements, the company has ROE of 21%.

ALPHA SPREAD
Join more than 129,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.